Ensysce Biosciences signs Merger Agreement with Cy Biopharma
Ensysce Biosciences, Inc. entered into an agreement and plan of merger with Cy Biopharma, Inc. The deal documents a strategic combination filed with the SEC on August 5, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day